Zygolide® is the first-to-market, FDA-approved generic peppermint flavored pergolide tablet for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses.
Each tablet contains 1 mg of pergolide and is bioequivalent to the pioneer product when administered orally to horses.
FDA approval of generics requires rigorous testing to confirm bioequivalence, which ensures the same safety, efficacy, and therapeutic effect as the pioneer product. You can expect Zygolide® to perform to the same clinical standard, even in challenging cases.
Zygolide® is formulated to appeal to horses, helping to ensure consistent daily dosing for effective management of PPID. It is a 360-degree half-scored tablet to help with accurate dosing.
Want to learn more?
Download our support materials below and contact our Veterinary Technical Support team at support@dechra.com or by calling (866) 933-2472.
Important Safety Information As with all drugs, side effects may occur. Zygolide® (pergolide tablets) is for use in horses only. Zygolide has not been evaluated in breeding, pregnant or lactating horses. Treatment with Zygolide may cause loss of appetite. Most cases are mild. If severe, a temporary dose reduction may be necessary. Weight loss, lack of energy, and behavioral changes also may be observed. Zygolide tablets should not be crushed due to the potential for increased human exposure. Pregnant or lactating women should wear gloves when administering this product. Zygolide is contraindicated in horses with hypersensitivity to pergolide mesylate or other ergot derivatives. Keep Zygolide in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Dogs have eaten pergolide tablets that were placed in food intended for horses or dropped during administration of the tablets to the horses. Adverse reactions may occur if animals other than horses ingest Zygolide tablets. Refer to the prescribing information for complete details or visit www.dechra-us.com.
*All personal information collected will be handled in accordance with Dechra's Privacy Policy, learn more here.